|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
11
|
Resverlogix Corp.
|
Jun 13, 2023 08:02AM
|
|
Re: Sales could take a hit
|
3
|
Resverlogix Corp.
|
Apr 17, 2023 02:05PM
|
|
Re: Sales could take a hit
|
5
|
Resverlogix Corp.
|
Apr 17, 2023 12:43PM
|
|
Re: Highest Volume days in last Five Years
|
3
|
Resverlogix Corp.
|
Apr 05, 2023 01:12PM
|
|
Re: Highest Volume days in last Five Years
|
3
|
Resverlogix Corp.
|
Apr 05, 2023 11:09AM
|
|
Re: Highest Volume days in last Five Years
|
4
|
Resverlogix Corp.
|
Apr 05, 2023 09:34AM
|
|
Re: Some history
|
6
|
Resverlogix Corp.
|
Jan 25, 2023 09:23AM
|
|
Re: IR
|
6
|
Resverlogix Corp.
|
Jan 10, 2023 10:54PM
|
|
Re: China- 1 Million daily COVID cases
|
4
|
Resverlogix Corp.
|
Jan 01, 2023 09:21AM
|
|
Re: can it be done legally
|
1
|
Resverlogix Corp.
|
Dec 14, 2022 10:11PM
|
|
Re: RVV insider purchases
|
2
|
Resverlogix Corp.
|
Dec 12, 2022 10:20PM
|
|
Re: RVV insider purchases
|
4
|
Resverlogix Corp.
|
Dec 12, 2022 07:06PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
4
|
Resverlogix Corp.
|
Nov 14, 2022 06:49PM
|
|
Re: find it interesting that RVXCF.....
|
5
|
Resverlogix Corp.
|
Nov 10, 2022 05:54PM
|
|
RVX…The Hawthorne Effect
|
4
|
Resverlogix Corp.
|
Oct 01, 2022 11:18AM
|
|
Re: Latest on COVID-19
|
6
|
Resverlogix Corp.
|
Sep 28, 2022 12:49PM
|
|
Re: No news, did you expect a change
|
9
|
Resverlogix Corp.
|
Sep 21, 2022 03:27PM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
2
|
Resverlogix Corp.
|
Aug 30, 2022 03:30PM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
5
|
Resverlogix Corp.
|
Aug 30, 2022 08:42AM
|
|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
4
|
Resverlogix Corp.
|
Aug 23, 2022 10:54PM
|
